CN Stock MarketDetailed Quotes

603676 Xizang Weixinkang Pharmaceutical

Watchlist
  • 9.87
  • -0.26-2.57%
Market Closed Nov 15 15:00 CST
4.30BMarket Cap17.38P/E (TTM)

Xizang Weixinkang Pharmaceutical Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-6.30%994.36M
-15.50%633.23M
-9.29%317.84M
-5.43%1.32B
-0.56%1.06B
12.18%749.41M
11.13%350.38M
35.31%1.4B
41.96%1.07B
33.63%668.04M
Operating revenue
-6.30%994.36M
-15.50%633.23M
-9.29%317.84M
-5.43%1.32B
-0.56%1.06B
12.18%749.41M
11.13%350.38M
35.31%1.4B
41.96%1.07B
33.63%668.04M
Other operating revenue
----
-47.48%119.27K
----
49.34%342.52K
----
98.01%227.08K
----
-23.04%229.36K
----
-24.94%114.68K
Total operating cost
-11.73%788.52M
-16.72%512.87M
-11.15%256.01M
-4.44%1.18B
-0.17%893.3M
9.17%615.85M
4.25%288.12M
31.01%1.23B
33.28%894.8M
29.26%564.14M
Operating cost
-14.93%450.38M
-21.02%290.67M
-16.93%143.93M
-1.86%650.55M
4.37%529.44M
13.22%368.01M
12.87%173.26M
32.47%662.88M
35.29%507.28M
30.26%325.04M
Operating tax surcharges
-8.24%10.55M
-15.75%6.76M
-14.66%3.52M
-8.19%14.04M
-4.43%11.49M
10.49%8.03M
8.42%4.12M
28.07%15.29M
29.00%12.02M
22.53%7.27M
Operating expense
-16.86%158.43M
-22.23%106.59M
-12.83%55.55M
-18.19%255.42M
-18.88%190.57M
-2.30%137.06M
-12.40%63.73M
13.31%312.19M
23.55%234.93M
11.15%140.29M
Administration expense
-0.14%94.58M
-4.51%60.22M
-9.46%27.93M
-13.60%148.43M
-7.23%94.72M
-8.55%63.06M
-14.34%30.85M
50.58%171.78M
37.31%102.09M
63.27%68.95M
Financial expense
29.07%-2.19M
19.37%-1.6M
8.20%-844.59K
-42.55%-4.34M
-31.29%-3.08M
-24.36%-1.99M
-22.71%-920.06K
-3,540.15%-3.05M
-457.23%-2.35M
-534.21%-1.6M
-Interest expense (Financial expense)
-29.34%194.64K
-16.20%148.23K
6.67%84.84K
80.61%342.29K
279.42%275.47K
386.12%176.88K
805.25%79.53K
65.08%189.52K
0.54%72.6K
-44.95%36.39K
-Interest Income (Financial expense)
27.51%-2.57M
20.67%-1.81M
12.29%-897.06K
-47.73%-4.91M
-41.99%-3.54M
-35.97%-2.28M
-31.77%-1.02M
-67.76%-3.32M
-130.87%-2.49M
-128.30%-1.68M
Research and development
9.39%76.76M
20.52%50.23M
51.71%25.93M
55.71%112.82M
71.88%70.17M
72.24%41.68M
54.72%17.09M
90.57%72.45M
85.97%40.82M
98.80%24.2M
Credit Impairment Loss
64.29%-878.29K
76.00%-734.99K
-37.39%-1.27M
932.70%1.9M
-71.57%-2.46M
-165.30%-3.06M
-7.49%-925.22K
81.89%-228.37K
-79.89%-1.43M
67.58%-1.15M
Asset Impairment Loss
25.23%-286.74K
124.91%78.71K
97.82%-2.43K
97.01%-696.1K
98.39%-383.49K
-196.21%-315.99K
82.52%-111.56K
-353.82%-23.31M
-34,744.20%-23.75M
529.73%328.44K
Other net revenue
200.00%27.71M
302.81%23.66M
-21.81%3.26M
764.98%29.22M
174.87%9.24M
-23.60%5.87M
41.34%4.17M
-150.52%-4.39M
-230.30%-12.34M
254.42%7.69M
Fair value change income
--2.89M
--4.37M
---618.22K
--11.58M
----
----
----
----
----
----
Invest income
38.25%12.76M
25.08%8.36M
-3.87%3.1M
-18.52%12.84M
-12.51%9.23M
-2.67%6.69M
-6.07%3.23M
39.13%15.76M
30.65%10.55M
42.99%6.87M
Asset deal income
93.20%-19.93K
---19.93K
---7.38K
-373.30%-436.23K
-2,243.79%-293.04K
----
----
158.79%159.61K
-135.33%-12.5K
-127.52%-10.95K
Other revenue
321.27%13.25M
352.20%11.6M
3.89%2.06M
24.83%4.04M
35.74%3.14M
55.04%2.57M
95.15%1.98M
-12.89%3.23M
4.14%2.32M
71.86%1.65M
Operating profit
31.87%233.55M
3.29%144.02M
-2.01%65.09M
7.60%174.96M
10.68%177.11M
24.95%139.43M
58.65%66.43M
58.97%162.6M
78.10%160.02M
69.98%111.59M
Add:Non operating Income
2.29%42.47M
9,809.18%42.47M
36,690.73%41.97M
106.13%41.54M
1,383,790.72%41.52M
14,185.01%428.55K
--114.08K
41.67%20.15M
-99.98%3K
-99.78%3K
Less:Non operating expense
2,523.57%5.86M
3,931.95%5.11M
823.35%481.43K
66.76%667.91K
-21.46%223.5K
-50.54%126.79K
51.36%52.14K
-82.45%400.52K
-81.94%284.57K
-61.29%256.34K
Total profit
23.69%270.15M
29.80%181.37M
60.30%106.58M
18.36%215.84M
36.72%218.4M
25.51%139.73M
58.93%66.49M
59.64%182.36M
58.06%159.74M
67.80%111.33M
Less:Income tax cost
229.43%26.89M
212.62%17.91M
86.89%11.67M
-66.25%1.82M
-6.73%8.16M
-31.47%5.73M
113.69%6.24M
-70.54%5.4M
-53.21%8.75M
-35.80%8.36M
Net profit
15.71%243.27M
21.98%163.46M
57.54%94.91M
20.94%214.02M
39.24%210.24M
30.13%134M
54.82%60.25M
84.50%176.96M
83.33%150.99M
93.10%102.97M
Net profit from continuing operation
15.71%243.27M
21.98%163.46M
57.54%94.91M
20.94%214.02M
39.24%210.24M
30.13%134M
54.82%60.25M
84.50%176.96M
83.33%150.99M
93.10%102.97M
Net profit of parent company owners
15.71%243.27M
21.98%163.46M
57.54%94.91M
20.94%214.02M
39.24%210.24M
30.13%134M
54.82%60.25M
84.50%176.96M
83.33%150.99M
93.10%102.97M
Earning per share
Basic earning per share
14.29%0.56
22.58%0.38
57.14%0.22
21.95%0.5
40.00%0.49
29.17%0.31
55.56%0.14
78.26%0.41
84.21%0.35
84.62%0.24
Diluted earning per share
14.29%0.56
22.58%0.38
57.14%0.22
21.95%0.5
40.00%0.49
29.17%0.31
55.56%0.14
78.26%0.41
84.21%0.35
84.62%0.24
Other composite income
-102.27%-185.33K
-95.11%222.26K
-98.01%28.67K
115.46%779.4K
-36.96%8.17M
-34.09%4.55M
-64.75%1.44M
-177.81%-5.04M
1,105.40%12.95M
756.42%6.9M
Other composite income of parent company owners
-102.27%-185.33K
-95.11%222.26K
-98.01%28.67K
115.46%779.4K
-36.96%8.17M
-34.09%4.55M
-64.75%1.44M
-177.81%-5.04M
1,105.40%12.95M
756.42%6.9M
Total composite income
11.30%243.08M
18.14%163.68M
53.91%94.94M
24.94%214.8M
33.22%218.41M
26.10%138.55M
43.44%61.69M
67.90%171.92M
102.22%163.94M
110.19%109.87M
Total composite income of parent company owners
11.30%243.08M
--163.68M
53.91%94.94M
24.94%214.8M
33.22%218.41M
----
43.44%61.69M
67.90%171.92M
102.22%163.94M
110.19%109.87M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -6.30%994.36M-15.50%633.23M-9.29%317.84M-5.43%1.32B-0.56%1.06B12.18%749.41M11.13%350.38M35.31%1.4B41.96%1.07B33.63%668.04M
Operating revenue -6.30%994.36M-15.50%633.23M-9.29%317.84M-5.43%1.32B-0.56%1.06B12.18%749.41M11.13%350.38M35.31%1.4B41.96%1.07B33.63%668.04M
Other operating revenue -----47.48%119.27K----49.34%342.52K----98.01%227.08K-----23.04%229.36K-----24.94%114.68K
Total operating cost -11.73%788.52M-16.72%512.87M-11.15%256.01M-4.44%1.18B-0.17%893.3M9.17%615.85M4.25%288.12M31.01%1.23B33.28%894.8M29.26%564.14M
Operating cost -14.93%450.38M-21.02%290.67M-16.93%143.93M-1.86%650.55M4.37%529.44M13.22%368.01M12.87%173.26M32.47%662.88M35.29%507.28M30.26%325.04M
Operating tax surcharges -8.24%10.55M-15.75%6.76M-14.66%3.52M-8.19%14.04M-4.43%11.49M10.49%8.03M8.42%4.12M28.07%15.29M29.00%12.02M22.53%7.27M
Operating expense -16.86%158.43M-22.23%106.59M-12.83%55.55M-18.19%255.42M-18.88%190.57M-2.30%137.06M-12.40%63.73M13.31%312.19M23.55%234.93M11.15%140.29M
Administration expense -0.14%94.58M-4.51%60.22M-9.46%27.93M-13.60%148.43M-7.23%94.72M-8.55%63.06M-14.34%30.85M50.58%171.78M37.31%102.09M63.27%68.95M
Financial expense 29.07%-2.19M19.37%-1.6M8.20%-844.59K-42.55%-4.34M-31.29%-3.08M-24.36%-1.99M-22.71%-920.06K-3,540.15%-3.05M-457.23%-2.35M-534.21%-1.6M
-Interest expense (Financial expense) -29.34%194.64K-16.20%148.23K6.67%84.84K80.61%342.29K279.42%275.47K386.12%176.88K805.25%79.53K65.08%189.52K0.54%72.6K-44.95%36.39K
-Interest Income (Financial expense) 27.51%-2.57M20.67%-1.81M12.29%-897.06K-47.73%-4.91M-41.99%-3.54M-35.97%-2.28M-31.77%-1.02M-67.76%-3.32M-130.87%-2.49M-128.30%-1.68M
Research and development 9.39%76.76M20.52%50.23M51.71%25.93M55.71%112.82M71.88%70.17M72.24%41.68M54.72%17.09M90.57%72.45M85.97%40.82M98.80%24.2M
Credit Impairment Loss 64.29%-878.29K76.00%-734.99K-37.39%-1.27M932.70%1.9M-71.57%-2.46M-165.30%-3.06M-7.49%-925.22K81.89%-228.37K-79.89%-1.43M67.58%-1.15M
Asset Impairment Loss 25.23%-286.74K124.91%78.71K97.82%-2.43K97.01%-696.1K98.39%-383.49K-196.21%-315.99K82.52%-111.56K-353.82%-23.31M-34,744.20%-23.75M529.73%328.44K
Other net revenue 200.00%27.71M302.81%23.66M-21.81%3.26M764.98%29.22M174.87%9.24M-23.60%5.87M41.34%4.17M-150.52%-4.39M-230.30%-12.34M254.42%7.69M
Fair value change income --2.89M--4.37M---618.22K--11.58M------------------------
Invest income 38.25%12.76M25.08%8.36M-3.87%3.1M-18.52%12.84M-12.51%9.23M-2.67%6.69M-6.07%3.23M39.13%15.76M30.65%10.55M42.99%6.87M
Asset deal income 93.20%-19.93K---19.93K---7.38K-373.30%-436.23K-2,243.79%-293.04K--------158.79%159.61K-135.33%-12.5K-127.52%-10.95K
Other revenue 321.27%13.25M352.20%11.6M3.89%2.06M24.83%4.04M35.74%3.14M55.04%2.57M95.15%1.98M-12.89%3.23M4.14%2.32M71.86%1.65M
Operating profit 31.87%233.55M3.29%144.02M-2.01%65.09M7.60%174.96M10.68%177.11M24.95%139.43M58.65%66.43M58.97%162.6M78.10%160.02M69.98%111.59M
Add:Non operating Income 2.29%42.47M9,809.18%42.47M36,690.73%41.97M106.13%41.54M1,383,790.72%41.52M14,185.01%428.55K--114.08K41.67%20.15M-99.98%3K-99.78%3K
Less:Non operating expense 2,523.57%5.86M3,931.95%5.11M823.35%481.43K66.76%667.91K-21.46%223.5K-50.54%126.79K51.36%52.14K-82.45%400.52K-81.94%284.57K-61.29%256.34K
Total profit 23.69%270.15M29.80%181.37M60.30%106.58M18.36%215.84M36.72%218.4M25.51%139.73M58.93%66.49M59.64%182.36M58.06%159.74M67.80%111.33M
Less:Income tax cost 229.43%26.89M212.62%17.91M86.89%11.67M-66.25%1.82M-6.73%8.16M-31.47%5.73M113.69%6.24M-70.54%5.4M-53.21%8.75M-35.80%8.36M
Net profit 15.71%243.27M21.98%163.46M57.54%94.91M20.94%214.02M39.24%210.24M30.13%134M54.82%60.25M84.50%176.96M83.33%150.99M93.10%102.97M
Net profit from continuing operation 15.71%243.27M21.98%163.46M57.54%94.91M20.94%214.02M39.24%210.24M30.13%134M54.82%60.25M84.50%176.96M83.33%150.99M93.10%102.97M
Net profit of parent company owners 15.71%243.27M21.98%163.46M57.54%94.91M20.94%214.02M39.24%210.24M30.13%134M54.82%60.25M84.50%176.96M83.33%150.99M93.10%102.97M
Earning per share
Basic earning per share 14.29%0.5622.58%0.3857.14%0.2221.95%0.540.00%0.4929.17%0.3155.56%0.1478.26%0.4184.21%0.3584.62%0.24
Diluted earning per share 14.29%0.5622.58%0.3857.14%0.2221.95%0.540.00%0.4929.17%0.3155.56%0.1478.26%0.4184.21%0.3584.62%0.24
Other composite income -102.27%-185.33K-95.11%222.26K-98.01%28.67K115.46%779.4K-36.96%8.17M-34.09%4.55M-64.75%1.44M-177.81%-5.04M1,105.40%12.95M756.42%6.9M
Other composite income of parent company owners -102.27%-185.33K-95.11%222.26K-98.01%28.67K115.46%779.4K-36.96%8.17M-34.09%4.55M-64.75%1.44M-177.81%-5.04M1,105.40%12.95M756.42%6.9M
Total composite income 11.30%243.08M18.14%163.68M53.91%94.94M24.94%214.8M33.22%218.41M26.10%138.55M43.44%61.69M67.90%171.92M102.22%163.94M110.19%109.87M
Total composite income of parent company owners 11.30%243.08M--163.68M53.91%94.94M24.94%214.8M33.22%218.41M----43.44%61.69M67.90%171.92M102.22%163.94M110.19%109.87M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data